Unknown

Dataset Information

0

Connectivity of the Cognitive Control Network During Response Inhibition as a Predictive and Response Biomarker in Major Depression: Evidence From a Randomized Clinical Trial.


ABSTRACT:

Background

In treating major depressive disorder, we lack tests anchored in neurobiology that predict antidepressant efficacy. Cognitive impairments are a particularly disabling feature of major depressive disorder. We tested whether functional connectivity during a response-inhibition task can predict response to antidepressants and whether its changes over time are correlated to symptom changes.

Methods

We analyzed data from outpatients with major depressive disorder (n = 124) randomized to receive escitalopram, sertraline, or venlafaxine (8 weeks) and healthy control subjects (n = 59; age 18-65 years). Before and after treatment, participants were interviewed and scanned using functional magnetic resonance imaging, and functional connectivity was measured using generalized psychophysiological interaction during response inhibition (Go-NoGo task). We investigated the interaction between treatment type and response (≥50% reduction on self-reported symptoms), coupling differences between responders and nonresponders at baseline, their correlation with symptom improvement, and their changes in time.

Results

During response inhibition, connectivity between the dorsolateral prefrontal cortex/supramarginal gyrus and supramarginal gyrus/middle temporal gyrus was associated with response to sertraline and venlafaxine, but not escitalopram. Sertraline responders had higher functional connectivity between these regions compared with nonresponders, whereas venlafaxine responders had lower functional connectivity. For sertraline, attenuation of connectivity in the precentral and superior temporal gyri correlated with posttreatment symptom improvement. For venlafaxine, enhancement of connectivity between the orbitofrontal cortex and subcortical regions correlated with symptom improvement.

Conclusions

Connectivity of the cognitive control circuit during response inhibition selectively and differentially predicts antidepressant treatment response and correlates with symptom improvement. These quantitative markers tied to the neurobiology of cognitive features of depression could be used translationally to predict and evaluate treatment response.

SUBMITTER: Tozzi L 

PROVIDER: S-EPMC8628639 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4689203 | biostudies-literature
| S-EPMC7416643 | biostudies-literature
| S-EPMC5416685 | biostudies-literature
| S-EPMC7178465 | biostudies-literature
| S-EPMC8476854 | biostudies-literature
| S-EPMC5908226 | biostudies-literature
| S-EPMC4869051 | biostudies-literature
| S-EPMC4233014 | biostudies-literature
| S-EPMC5437875 | biostudies-other
| S-EPMC5426983 | biostudies-literature